$1.28
0.02[1.59%]
At close: Apr 22
$1.28
0[0.00%]
PreMarket: 6:52PM EDT
Cyclo Therapeutics
(NASDAQ:CYTH)Cyclo Therapeutics Stock (NASDAQ:CYTH), Analyst Ratings, Price Targets, Predictions
Cyclo Therapeutics Inc has a consensus price target of $3.3, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Ascendiant Capital, Maxim Group, and Maxim Group on April 22, 2024, September 27, 2023, and March 21, 2023. With an average price target of $2.2 between Ascendiant Capital, Maxim Group, and Maxim Group, there's an implied 71.87% upside for Cyclo Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
Maxim Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cyclo Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | CYTH | Buy Now | Cyclo Therapeutics | $1.28 | 103.13% | Ascendiant Capital | Lucas Ward | → $2.6 | Initiates | → Buy | Get Alert |
| 09/27/2023 | CYTH | Buy Now | Cyclo Therapeutics | $1.28 | 212.5% | Maxim Group | Jason McCarthy | → $4 | Upgrade | Hold → Buy | Get Alert |
| 03/21/2023 | CYTH | Buy Now | Cyclo Therapeutics | $1.28 | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Cyclo Therapeutics (CYTH)?
The latest price target for Cyclo Therapeutics (NASDAQ: CYTH) was reported by Ascendiant Capital on April 22, 2024. The analyst firm set a price target for $2.60 expecting CYTH to rise to within 12 months (a possible 103.13% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cyclo Therapeutics (CYTH)?
The latest analyst rating for Cyclo Therapeutics (NASDAQ: CYTH) was provided by Ascendiant Capital, and Cyclo Therapeutics initiated their buy rating.
When was the last upgrade for Cyclo Therapeutics (CYTH)?
The last upgrade for Cyclo Therapeutics Inc happened on September 27, 2023 when Maxim Group raised their price target to $4. Maxim Group previously had a hold for Cyclo Therapeutics Inc.
When was the last downgrade for Cyclo Therapeutics (CYTH)?
The last downgrade for Cyclo Therapeutics Inc happened on March 21, 2023 when Maxim Group changed their price target from N/A to N/A for Cyclo Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Cyclo Therapeutics (CYTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cyclo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cyclo Therapeutics was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating Cyclo Therapeutics (CYTH) correct?
While ratings are subjective and will change, the latest Cyclo Therapeutics (CYTH) rating was a initiated with a price target of $0.00 to $2.60. The current price Cyclo Therapeutics (CYTH) is trading at is $1.28, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.